High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients

Autoantibodies against thyroid hormones (THAbs) directed towards triiodothyronine (T3‐Ab) and/or thyroxine (T4‐Ab) are very rare in the general population. They are increased in some nonthyroidal autoimmune diseases, where they seem to predict autoimmune thyroid disorders (ATDs). So far, their presence in patients with vitiligo has not been evaluated, but it might have a possible predictive role.

[1]  J. Kline,et al.  Autoimmune signals in non‐segmental vitiligo patients are associated with distinct clinical parameters and toxic exposures , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  S. Moretti,et al.  Commentary from the Editorial Board to Vitiligo: interplay between oxidative stress and immune system (Laddha et al.) , 2013, Experimental dermatology.

[3]  T. Jouary,et al.  Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms , 2013, The British journal of dermatology.

[4]  M. Mansuri,et al.  Vitiligo: interplay between oxidative stress and immune system , 2013, Experimental dermatology.

[5]  R. Geskus,et al.  High Prevalence of Autoimmune Thyroiditis in Children and Adolescents with Vitiligo , 2013, Hormone Research in Paediatrics.

[6]  A. Mohammadi,et al.  Enhanced oxidative stress in Hashimoto's thyroiditis: inter-relationships to biomarkers of thyroid function. , 2013, Clinical biochemistry.

[7]  T. Nijsten,et al.  Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners , 2013, The British journal of dermatology.

[8]  A. Wolkerstorfer,et al.  The prevalence of thyroid disease in patients with vitiligo: a systematic review , 2012, The British journal of dermatology.

[9]  O. Finn,et al.  Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  J. Kline,et al.  Autoimmune markers in vitiligo patients appear correlated with obsession and phobia , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  D. Cooper,et al.  The incidence and prevalence of thyroid autoimmunity , 2012, Endocrine.

[12]  Jinhyuk Lee,et al.  Computational Prediction of Protein-Protein Interactions of Human Tyrosinase , 2012, Enzyme research.

[13]  T. Jouary,et al.  Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo , 2012, The British journal of dermatology.

[14]  Ruchita Sharma,et al.  Autoimmune thyroid disease in patients with vitiligo: prevalence study in India. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[15]  R. Sánchez-Porras,et al.  Immunopathogenesis of vitiligo. , 2011, Autoimmunity reviews.

[16]  Meaghan Daly,et al.  Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. , 2011, Journal of the American Academy of Dermatology.

[17]  Ji-Hye Park,et al.  The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment , 2011, International journal of dermatology.

[18]  B. Begović,et al.  Association between Vitiligo and Thyroid Autoimmunity , 2011, Journal of thyroid research.

[19]  W. Westerhof,et al.  The haptenation theory of vitiligo and melanoma rejection: a close‐up , 2011, Experimental dermatology.

[20]  Franck Pagès,et al.  Tumor immunosurveillance in human cancers , 2011, Cancer and Metastasis Reviews.

[21]  J. Nordlund.  Nonmelanoma skin cancer in vitiligo patients. , 2009, Journal of the American Academy of Dermatology.

[22]  F. Solano,et al.  New insights into the active site structure and catalytic mechanism of tyrosinase and its related proteins , 2009, Pigment cell & melanoma research.

[23]  M. Picardo,et al.  Clinical practice. Vitiligo. , 2009, The New England journal of medicine.

[24]  M. Zeegers,et al.  Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? , 2008, Experimental dermatology.

[25]  M. Picardo,et al.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. , 2007, Pigment cell research.

[26]  Y. Erbil,et al.  Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease. , 2006, European journal of internal medicine.

[27]  N. J. Gibbons,et al.  Butyrylcholinesterase is present in the human epidermis and is regulated by H2O2: more evidence for oxidative stress in vitiligo. , 2006, Biochemical and biophysical research communications.

[28]  M. Picardo,et al.  A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. , 2006, Pigment cell research.

[29]  N. J. Gibbons,et al.  Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo. , 2004, Biochemical and biophysical research communications.

[30]  A. J.,et al.  Anti-Triiodothyronine Autoantibodies Interfere with Two Recently Commercialized Radioimmunoassays for Free Triiodothyronine , 2004 .

[31]  F. Trimarchi,et al.  Thyroid hormone autoantibodies in Hashimoto's thyroiditis: often transient but also increasingly frequent. , 2003, Thyroid : official journal of the American Thyroid Association.

[32]  J. Naeyaert,et al.  Evidence for an autoimmune pathogenesis of vitiligo. , 2003, Pigment cell research.

[33]  F. Trimarchi,et al.  Triggering of thyroid hormone autoantibodies. , 2003, Journal of the Royal Society of Medicine.

[34]  F. Trimarchi,et al.  Heterogeneity of the thyroglobulin epitopes associated with circulating thyroid hormone autoantibodies in Hashimoto’s thyroiditis and non-autoimmune thyroid diseases , 2002, Journal of endocrinological investigation.

[35]  D. Tobin,et al.  Decreased Photodamage and Low Incidence of Non-Melanoma Skin Cancer in 136 Sun-Exposed Caucasian Patients with Vitiligo , 2002, Dermatology.

[36]  F. Trimarchi,et al.  Thyroid hormone autoantibodies in primary Sjögren syndrome and rheumatoid arthritis are more prevalent than in autoimmune thyroid disease, becoming progressively more frequent in these diseases , 2002, Journal of endocrinological investigation.

[37]  R. Nachreiner,et al.  Prevalence of serum thyroid hormone autoantibodies in dogs with clinical signs of hypothyroidism. , 2002, Journal of the American Veterinary Medical Association.

[38]  A. Giraud,et al.  Hydrogen peroxide-induced production of a 40 kDa immunoreactive thyroglobulin fragment in human thyroid cells: the onset of thyroid autoimmunity? , 2001, The Biochemical journal.

[39]  F. Giallauria,et al.  The disulfide bond pattern between fragments obtained by the limited proteolysis of bovine thyroglobulin. , 1999, Biochimie.

[40]  C. Jahoda.  Cellular and developmental aspects of androgenetic alopecia , 1998, Experimental dermatology.

[41]  N. Després,et al.  Antibody interference in thyroid assays: a potential for clinical misinformation. , 1998, Clinical chemistry.

[42]  F. Trimarchi,et al.  Thyroid hormone autoantibodies elicited by diagnostic fine needle biopsy. , 1997, The Journal of clinical endocrinology and metabolism.

[43]  M. Westhofen,et al.  Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. , 1994, Dermatology.

[44]  E. Krejci,et al.  Cholinesterase-like domains in enzymes and structural proteins: functional and evolutionary relationships and identification of a catalytically essential aspartic acid. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[45]  T. Omura,et al.  Evolutionary origin of thyroglobulin by duplication of esterase gene , 1991, FEBS letters.

[46]  B. Iyengar.  Modulation of melanocytic activity by acetylcholine. , 1989, Acta anatomica.

[47]  F. Trimarchi,et al.  Autoantibodies to thyroxin and triiodothyronine in the immunoglobulin G fraction of serum. , 1988, Clinical chemistry.

[48]  F. Trimarchi,et al.  Circulating thyroid hormone autoantibodies , 1987, Journal of endocrinological investigation.

[49]  K. Miura,et al.  Autoantibodies against thyroid hormones or iodothyronine. Implications in diagnosis, thyroid function, treatment, and pathogenesis. , 1985, Annals of internal medicine.

[50]  A. Peserico,et al.  Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. , 1985, Dermatologica.

[51]  J. Ordóñez‐Llanos,et al.  Antibody binding serum T3 in a patient with hepatocarcinoma , 1984, Journal of endocrinological investigation.

[52]  J. Rodríguez-Espinosa,et al.  Anti-triiodothyronine autoantibodies interfere with two recently commercialized radioimmunoassays for free triiodothyronine. , 1984, Clinical chemistry.

[53]  C L Rümke,et al.  [Incidence and prevalence]. , 1983, Nederlands tijdschrift voor geneeskunde.

[54]  F. Trimarchi,et al.  Immunoglobulin binding of thyroid hormones in a case of Waldenstrom's macroglobulinemia. , 1982, The Journal of clinical endocrinology and metabolism.

[55]  J. E. Rall,et al.  An unusual instance of thyroxine-binding by human serum gamma globulin. , 1956, The Journal of clinical endocrinology and metabolism.